Previous studies have reported that the ACE2 levels decreased during the SARS-CoV infection, and ACE2 is known for its effect as the main counterregulatory enzyme to ACE that functions by the breakdown of degrading angiotensin II [39, 40]. The gene discussed is ACE2; the disease is severe acute respiratory syndrome.